Noubar Afeyan

(Dr. Noubar Afeyan Ph.D.)

Currently holds positions in Rubius Therapeutics Inc and Moderna Inc

Positions
Position Company Period
Independent Director Rubius Therapeutics Inc Jan. 1, 2013 -
Non-Executive Independent Chairman of the Board, Co-Founder Moderna Inc Feb. 1, 2012 -
Lead Independent Director Seres Therapeutics Inc Jan. 1, 2016 - March 23, 2020
Chairman of the Board Evelo Biosciences Inc Jan. 1, 2017 - Sept. 17, 2019
Director Evelo Biosciences Inc None -
Director Seres Therapeutics Inc Oct. 1, 2010 - Jan. 1, 2016
Director Sesen Bio Inc Feb. 1, 2008 - Nov. 12, 2014
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2021-02-24 2021-02-24
US Moderna Inc (MRNA)
PS Planned sale
358,528 -2.5%
144.17
51,688,838 USD 		358,528 -2.5% 144.17 51,688,838 USD
2021-02-24 2021-02-23
US Moderna Inc (MRNA)
PS Planned sale
23,423 -0.2%
151.29
3,543,551 USD 		23,423 -0.2% 151.29 3,543,551 USD
2021-02-24 2021-02-23
US Moderna Inc (MRNA)
PS Planned sale
190,710 -1.3%
150.51
28,704,468 USD 		190,710 -1.3% 150.51 28,704,468 USD
2021-02-24 2021-02-23
US Moderna Inc (MRNA)
PS Planned sale
179,268 -1.2%
149.63
26,823,154 USD 		179,268 -1.2% 149.63 26,823,154 USD
2021-02-24 2021-02-23
US Moderna Inc (MRNA)
PS Planned sale
268,688 -1.8%
148.52
39,905,810 USD 		268,688 -1.8% 148.52 39,905,810 USD
2021-02-24 2021-02-23
US Moderna Inc (MRNA)
PS Planned sale
292,483 -1.9%
147.57
43,162,565 USD 		292,483 -1.9% 147.57 43,162,565 USD
2021-02-24 2021-02-23
US Moderna Inc (MRNA)
PS Planned sale
307,795 -1.9%
146.64
45,134,105 USD 		307,795 -1.9% 146.64 45,134,105 USD
2021-02-24 2021-02-23
US Moderna Inc (MRNA)
PS Planned sale
357,316 -2.2%
145.48
51,982,439 USD 		357,316 -2.2% 145.48 51,982,439 USD
2021-02-24 2021-02-23
US Moderna Inc (MRNA)
PS Planned sale
405,551 -2.4%
144.55
58,623,573 USD 		405,551 -2.4% 144.55 58,623,573 USD
2021-02-24 2021-02-23
US Moderna Inc (MRNA)
PS Planned sale
397,126 -2.3%
143.57
57,017,127 USD 		397,126 -2.3% 143.57 57,017,127 USD
2021-02-24 2021-02-23
US Moderna Inc (MRNA)
PS Planned sale
117,011 -0.7%
142.76
16,704,549 USD 		117,011 -0.7% 142.76 16,704,549 USD
2021-02-24 2021-02-23
US Moderna Inc (MRNA)
PS Planned sale
70,631 -0.4%
141.46
9,991,271 USD 		70,631 -0.4% 141.46 9,991,271 USD
2021-02-24 2021-02-23
US Moderna Inc (MRNA)
PS Planned sale
102,852 -0.6%
140.24
14,423,553 USD 		102,852 -0.6% 140.24 14,423,553 USD
2021-02-24 2021-02-23
US Moderna Inc (MRNA)
PS Planned sale
56,435 -0.3%
139.64
7,880,849 USD 		56,435 -0.3% 139.64 7,880,849 USD
2021-02-24 2021-02-23
US Moderna Inc (MRNA)
PS Planned sale
46,222 -0.3%
138.56
6,404,451 USD 		46,222 -0.3% 138.56 6,404,451 USD
2021-02-24 2021-02-23
US Moderna Inc (MRNA)
PS Planned sale
122,142 -0.7%
137.29
16,768,948 USD 		122,142 -0.7% 137.29 16,768,948 USD
2021-02-24 2021-02-23
US Moderna Inc (MRNA)
PS Planned sale
9,985 -0.1%
136.48
1,362,773 USD 		9,985 -0.1% 136.48 1,362,773 USD
2021-02-24 2021-02-22
US Moderna Inc (MRNA)
PS Planned sale
30,968 -0.2%
170.03
5,265,421 USD 		30,968 -0.2% 170.03 5,265,421 USD
2021-02-24 2021-02-22
US Moderna Inc (MRNA)
PS Planned sale
54,274 -0.3%
169.14
9,179,910 USD 		54,274 -0.3% 169.14 9,179,910 USD
2021-02-24 2021-02-22
US Moderna Inc (MRNA)
PS Planned sale
58,377 -0.3%
168.11
9,813,857 USD 		58,377 -0.3% 168.11 9,813,857 USD
2021-02-24 2021-02-22
US Moderna Inc (MRNA)
PS Planned sale
122,715 -0.7%
167.10
20,505,750 USD 		122,715 -0.7% 167.10 20,505,750 USD
2021-02-24 2021-02-22
US Moderna Inc (MRNA)
PS Planned sale
351,578 -1.9%
166.30
58,466,296 USD 		351,578 -1.9% 166.30 58,466,296 USD
2021-02-24 2021-02-22
US Moderna Inc (MRNA)
PS Planned sale
165,578 -0.9%
165.47
27,397,976 USD 		165,578 -0.9% 165.47 27,397,976 USD
2021-02-24 2021-02-22
US Moderna Inc (MRNA)
PS Planned sale
189,200 -1.0%
164.13
31,054,266 USD 		189,200 -1.0% 164.13 31,054,266 USD
2021-02-24 2021-02-22
US Moderna Inc (MRNA)
PS Planned sale
366,471 -1.9%
163.25
59,827,380 USD 		366,471 -1.9% 163.25 59,827,380 USD
2021-02-24 2021-02-22
US Moderna Inc (MRNA)
PS Planned sale
250,501 -1.3%
162.36
40,672,044 USD 		250,501 -1.3% 162.36 40,672,044 USD
2021-02-24 2021-02-22
US Moderna Inc (MRNA)
PS Planned sale
30,808 -0.2%
160.96
4,958,809 USD 		30,808 -0.2% 160.96 4,958,809 USD
2021-02-24 2021-02-22
US Moderna Inc (MRNA)
PS Planned sale
54,409 -0.3%
160.37
8,725,620 USD 		54,409 -0.3% 160.37 8,725,620 USD
2021-02-24 2021-02-22
US Moderna Inc (MRNA)
PS Planned sale
161,887 -0.8%
159.18
25,769,076 USD 		161,887 -0.8% 159.18 25,769,076 USD
2019-06-20 2019-06-18
B Purchase
4,444,444 +inf%
2.25
9,999,999 USD 		4,444,444 +inf% 2.25 9,999,999 USD
2019-06-20 2019-06-18
B Purchase
4,444,444 +inf%
2.25
9,999,999 USD 		4,444,444 +inf% 2.25 9,999,999 USD